Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1032 of 5804
-
Could a simple talk therapy help struggling mothers in peru? new trial aims to find out
Disease control Recruiting nowRecent advances in intervention research have revealed the promise of transdiagnostic, modular approaches implemented by lay paraprofessionals for the treatment of the most prevalent mental health concerns in settings affected by adversity (e.g., anxiety, depression, posttraumati…
Phase: PHASE2 • Sponsor: University of Notre Dame • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Hearing loss shield: new drug may protect ears during chemo
Symptom relief Recruiting nowThe purpose of this study is to assess the safety and effectiveness of a drug called Pedmark® sodium thiosulfate (STS) in reducing hearing impairment with standard of care cisplatin therapy. The safety and effectiveness of STS in reducing hearing loss has been well established in…
Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Cool roofs could beat the heat in fiji: 800 homes join landmark study
Disease control Not yet recruitingAmbient air temperatures in Fiji are increasing due to climate change. Solutions are needed to build heat resilience in communities and adapt. Sunlight-reflecting cool roof coatings may passively reduce indoor temperatures and energy use to protect home occupants from extreme hea…
Phase: NA • Sponsor: Aditi Bunker • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Digital lifeline: new online tool aims to ease mental health distress for young people stuck on waiting lists
Symptom relief Not yet recruitingThis study, run by Amsterdam UMC in the Netherlands, looks at whether an online mental health platform called ENYOY can help improve psychological distress in young people (16-25) who are waiting for mental health care. Young people in the Netherlands aged 16 to 25 can take part …
Phase: NA • Sponsor: Academisch Medisch Centrum - Amsterdam UMC Research BV • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
AI to predict cancer risk from gut bacteria and scans
Knowledge-focused Not yet recruitingUpper digestive tract cancers are often preceded by pre-malignant lesions, but there is limited evidence regarding optimal risk prediction models and screening strategies for disease progression and cancer development. This prospective multicenter cohort study aims to establish a…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Wire-Free heart scan could cut unnecessary stents in heart attack patients
Disease control Not yet recruitingAcute coronary syndromes (ACS) are frequently associated with multivessel coronary artery disease (CAD), and current guidelines recommend complete revascularization beyond the culprit lesion. Angiography-guided PCI is the standard approach, but anatomical assessment does not alwa…
Phase: NA • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Neck injection offers new hope for Tough-to-Treat PTSD
Symptom relief Recruiting nowPTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression…
Phase: PHASE4 • Sponsor: Dr. Dean Reeves Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New drug combo targets tough breast cancer in Real-World study
Disease control Not yet recruitingA Multicenter, Observational Study on the Real-World Effectiveness and Safety of inavolisib Combined with Endocrine Therapy With or Without a CDK4/6 Inhibitor in Patients with HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer.
Sponsor: xuliang • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could Low-Dose radiation slow Alzheimer's? new trial aims to find out
Disease control Not yet recruitingThe goal of this randomized clinical trial is to investigate whether low-dose whole-brain radiotherapy has a potential immunomodulatory effect that may influence disease progression in patients with early-stage Alzheimer's disease (ICD-10 diagnosed). The main question(s) it aims…
Phase: NA • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug combo aims to tackle obesity in major trial
Disease control Recruiting nowThe main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to examine the body weight-lowering efficacy and safety of macupatide plus eloralintide compared with placebo in participants with obesity or overweight and without type 2 diabetes. …
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Magnetic pulses aim to restore speech after stroke
Symptom relief Recruiting nowThis project aims to tailor repetitive Transcranial Magnetic Stimulation (rTMS) target to the clinical profile of post-stroke aphasia, specifically focusing on lexicosemantic impairments, to enhance recovery. Functional Magnetic Resonance Imaging (fMRI) will provide critical insi…
Phase: NA • Sponsor: University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New drug cocktail aims to boost lung cancer treatment before radiation
Disease control Not yet recruitingThe goal of this clinical trial is to compare the efficacy and safety of induction Benmelstobart plus Anlotinib and chemotherapy followed by concurrent chemoradiotherapy (CCRT) and subsequent Benmelstobart maintenance versus CCRT followed by Benmelstobart maintenance in patients …
Phase: PHASE2 • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for women with mysterious chest pain: tailored treatment on the horizon
Disease control Not yet recruitingThis prospective single-center interventional study will include women with angina and non-obstructive coronary arteries. Participants will undergo a standardized invasive coronary assessment combining coronary physiology, acetylcholine provocation testing, and optical coherence …
Phase: NA • Sponsor: Hospital de Clínicas Dr. Manuel Quintela • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a common diabetes drug boost immunotherapy in Hard-to-Treat cancers?
Disease control Not yet recruitingThis study is testing whether adding the drug sitagliptin to the standard immunotherapy pembrolizumab is safe and may help people with advanced melanoma or advanced renal cell carcinoma (kidney cancer) whose cancer has stopped responding to prior PD-1 or PD-L1 immunotherapy. The…
Phase: PHASE1 • Sponsor: Fernando Maciel Barbosa • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New cream aims to tame burn scars – trial underway
Symptom relief Recruiting nowThe goal of this study is to see how an ingredient called kynurenic acid (which we named "FS2") affects scar formation in people with burn injuries that need skin graft surgery. A cream with FS2 will be used on both the area where the skin graft was placed and the area where the …
Phase: PHASE2, PHASE3 • Sponsor: Birch BioMed Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
One pill to prevent HIV and pregnancy? new study tests simpler option for women
Prevention Not yet recruitingTo evaluate adherence to a single dual-prevention pill (DPP) compared with a two-pill regimen (2PR) for pre-exposure prophylaxis (PrEP) and pregnancy prevention in women without HIV.
Phase: PHASE2 • Sponsor: HIV Prevention Trials Network • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
New combo drug trial hopes to shrink Hard-to-Treat cancers
Disease control Not yet recruitingThis study is a multi-center, open-label, dose-escalation and dose-optimized phase I/II clinical trial. Objective: To determine the safety, tolerability, PK characteristics and preliminary efficacy data of CVL006 combined with 9MW821 patients with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug cocktail aims to Re-Sensitize Immunotherapy-Resistant lung cancer
Disease control Not yet recruitingThis is a prospective, single-arm, multi-center, phase II clinical trial to evaluate the efficacy and safety of Chidamide in combination with Ivonescimab in the treatment of advanced non-small cell lung cancer with secondary immune resistance and high YAP protein expression.
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Mindfulness program aims to help cancer survivors kick smoking and cut alcohol
Symptom relief Recruiting nowThis study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through stru…
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
MRNA injection aims to turn back the clock on aging
Disease control Not yet recruitingThis is a Phase 1b randomized, double-blind, placebo-controlled study to assess the safety and tolerability of a proprietary aKLmRNA formulated in lipid nanoparticles. Approximately 21 subjects will be enrolled. Each subject will receive a total of two injections during the stud…
Phase: PHASE1 • Sponsor: Klothea Bio Inc • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC